West Pharmaceutical Services Inc (WST) has declared a quarterly dividend of $0.22 per share, payable on February 3, 2026, to shareholders of record as of January 27, 2026. This decision underscores the company's commitment to providing regular income to its shareholders, with a current dividend yield of 0.33%.
Investors must own shares prior to the ex-dividend date of January 27, 2026, to qualify for this payment. The company continues to maintain a consistent dividend policy, reflecting its ongoing cash flow generation and capital allocation strategy.
Headquartered in Exton, Pennsylvania, West Pharmaceutical Services engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. As of November 25, 2025, West Pharmaceutical has a market capitalization of $19.5 billion and a P/E ratio of 39.66.
Looking ahead, the company is scheduled to report its next earnings on July 22, 2026, with an estimated EPS of $1.97 and revenue of $823.4 million. Such financial metrics provide further context for investors considering the sustainability of its dividend payments.